T1	Treatment 0 22	Phosphorylated p-70S6K
T2	Treatment 32 41	tamoxifen
T3	Treatment 122 131	tamoxifen
T4	Treatment 139 161	no systemic treatment.
T5	Treatment 194 230	phosphatidylinositol-3-kinase (PI3K)
T6	Treatment 238 277	mitogen-activated protein kinase (MAPK)
T7	Treatment 492 509	endocrine therapy
T8	Treatment 549 566	rapamycine (mTOR)
T9	Treatment 637 665	adjuvant endocrine treatment
T10	Treatment 962 971	tamoxifen
T11	Treatment 1133 1183	adjuvant tamoxifen (1-3 years) versus observation.
T12	Treatment 1205 1223	tissue micro-array
T13	Treatment 1487 1500	and tamoxifen
T14	Treatment 1558 1624	between tamoxifen and p-AKT(Thr308), p-mTOR, p-p70S6K and p-ERK1/2
T15	Treatment 1673 1681	p-p70S6K
T16	Treatment 1716 1730	with tamoxifen
T17	Treatment 1810 1824	from tamoxifen
T18	Treatment 2239 2257	adjuvant tamoxifen
